Mepolizumab

BPS Bioscience

Mepolizumab

23

Research Use Only

Monoclonal

≥90%

Human

IgG1

Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma.1,2

2°C to 8°C

12352203